Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 39.39% vs -10.81% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 33.18% vs -1.94% in Mar 2024
Compare Balance Sheet Results of Brawn Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.00
2.93
0.07
2.39%
Share Warrants & Outstandings
Total Reserve
0.36
-3.41
3.77
110.56%
Shareholder's Funds
3.36
-0.49
3.85
785.71%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.51
0.00
-0.51
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
7.71
0.00
7.71
0.00%
Long Term Provisions
0.09
0.00
0.09
0.00%
Total Non-Current Liabilities
7.29
0.00
7.29
0.00%
Current Liabilities
Trade Payables
8.24
0.00
8.24
0.00%
Other Current Liabilities
1.01
0.00
1.01
0.00%
Short Term Borrowings
0.00
4.16
-4.16
-100.00%
Short Term Provisions
0.08
0.27
-0.19
-70.37%
Total Current Liabilities
9.33
4.43
4.90
110.61%
Total Liabilities
19.97
3.95
16.02
405.57%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.02
0.00
1.02
0.00%
Less: Accumulated Depreciation
0.56
0.00
0.56
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.46
0.00
0.46
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
2.01
0.00
2.01
0.00%
Total Non-Current Assets
2.47
0.00
2.47
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
10.47
3.93
6.54
166.41%
Sundry Debtors
3.41
0.00
3.41
0.00%
Cash and Bank
0.20
0.02
0.18
900.00%
Other Current Assets
0.20
0.00
0.20
0.00%
Short Term Loans and Advances
3.22
0.00
3.22
0.00%
Total Current Assets
17.50
3.95
13.55
343.04%
Net Current Assets (Including Current Investments)
8.17
-0.49
8.66
1,767.35%
Total Current Assets Excluding Current Investments
17.50
3.95
13.55
343.04%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
19.97
3.95
16.02
405.57%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
4.16
-4.16
-100.00%
Book Value per share (adjusted)
11.21
-1.66
12.87
775.30%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 39.39% vs -10.81% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 17.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 33.18% vs -1.94% in Mar 2024
